Form 8-K - Current report:
SEC Accession No. 0001104659-21-116919
Filing Date
2021-09-17
Accepted
2021-09-17 16:16:05
Documents
15
Period of Report
2021-09-13
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2127647d1_8k.htm   iXBRL 8-K 28705
2 EXHIBIT 10.1 tm2127647d1_ex10-1.htm EX-10.1 113519
3 EXHIBIT 99.1 tm2127647d1_ex99-1.htm EX-99.1 14728
7 GRAPHIC tm2127647d1_ex99-1img001.jpg GRAPHIC 6406
  Complete submission text file 0001104659-21-116919.txt   367867

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA jagx-20210913.xsd EX-101.SCH 3054
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE jagx-20210913_lab.xml EX-101.LAB 34239
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE jagx-20210913_pre.xml EX-101.PRE 22378
8 EXTRACTED XBRL INSTANCE DOCUMENT tm2127647d1_8k_htm.xml XML 3651
Mailing Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104
Business Address 200 PINE STREET SUITE 400 SAN FRANCISCO CA 94104 415-371-8300
Jaguar Health, Inc. (Filer) CIK: 0001585608 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36714 | Film No.: 211260607
SIC: 2834 Pharmaceutical Preparations